Inula racemosa ameliorates acute lung injury through integrated modulation of innate immune signalling, inflammation activation and redox homeostasis

Phulwanti Kumari Sharma; Gaurav Sharma; Sudipta Kumar Rath

doi:10.18203/issn.2454-2156.IntJSciRep20263677

Authors

Phulwanti Kumari Sharma Department of Dravyaguna, National Institute of Ayurveda (Deemed to be University), Jaipur, Rajasthan, India; Drug Discovery and Development Unit, National Institute of Ayurveda (Deemed to be University), Jaipur, Rajasthan, India
Gaurav Sharma Department of Dravyaguna, National Institute of Ayurveda (Deemed to be University), Jaipur, Rajasthan, India; Drug Discovery and Development Unit, National Institute of Ayurveda (Deemed to be University), Jaipur, Rajasthan, India
Sudipta Kumar Rath Department of Dravyaguna, National Institute of Ayurveda (Deemed to be University), Jaipur, Rajasthan, India; Drug Discovery and Development Unit, National Institute of Ayurveda (Deemed to be University), Jaipur, Rajasthan, India

DOI:

https://doi.org/10.18203/issn.2454-2156.IntJSciRep20263677

Keywords:

Inula racemosa, Cytokines, Lung inflammation, LPS, COVID-19

Abstract

Background: Chronic respiratory diseases are associated with persistent inflammation and dysregulated immune responses. Although corticosteroids are widely used, prolonged therapy may cause immunosuppression and increase susceptibility to secondary infections. Inula racemosa (IR) Hook. F. (Pushkarmool), an Ayurvedic medicinal plant traditionally used for respiratory and inflammatory disorders, contains bioactive sesquiterpene lactones, particularly alantolactone and isoalantolactone, with reported anti-inflammatory and immunomodulatory activities.

Methods: The study employed human lung epithelial NCI-H460 cells and an lipopolysaccharide (LPS) induced pulmonary inflammation model in BALB/c mice. Cytotoxicity and inflammatory responses were evaluated following treatment with IR extract. Gene expression of key inflammatory and signalling markers was analysed by RT-qPCR, while protein levels of inflammatory cytokines were quantified using ELISA. Cytokine profiling, BALF cellular analysis, and lung histopathological examination were performed to assess the anti-inflammatory effects of the extract. The expression of genes associated with the TLR4/MyD88/NF-κB, MAPK, NLRP3 inflammasome, and Nrf2/HO-1 pathways was investigated to elucidate the potential molecular mechanisms underlying observed effects.

Results: IR extract attenuated LPS-induced inflammatory responses in NCI-H460 cells, with reduced production of TNF-α, IL-6, IL-1β, IL-8, IL-18, IL-4, and CCL2. In LPS-challenged BALB/c mice, treatment reduced inflammatory cell infiltration, including neutrophils, in BAL fluid and improved inflammation-associated histopathological alterations in lung tissue.

Conclusions: The findings demonstrate that whole IR extract possesses significant anti-inflammatory activity in cellular and experimental pulmonary inflammation models. Its effects may involve modulation of multiple inflammatory and antioxidant signalling pathways. These findings provide experimental support for the traditional use of IR in respiratory inflammatory conditions and warrant further mechanistic and translational investigations.

References

Medzhitov R. Inflammation 2010: New adventures of an old flame. Cell. 2010;140(6):771-6.

Nathan C, Ding A. Nonresolving inflammation. Cell. 2010;140(6):871-82.

Gundeti MS, Bhurke LW, Mundkinajeddu D. Traditional medicine in India. J Tradit Chinese Med Sci. 2021;8(4):294-305.

Gundeti MS, Bhurke LW, Mundada PS, Murudkar S, Surve A, Sharma R, et al. AYUSH 64, a polyherbal Ayurvedic formulation in influenza-like illness: Results of a pilot study. J Ayurveda Integrative Med. 2022;13(3):100325.

Ma S, Wang X, Lai F, Lou C. The beneficial pharmacological effects and potential mechanisms of picroside II: Evidence of its benefits from in vitro and in vivo. Biomed Pharmacother. 2020;130:110421.

Khyade MS, Kasote DM, Vaikos NP. Alstonia scholaris (L.) R.Br. and Alstonia macrophylla Wall. ex G. Don: A comparative review on traditional uses, phytochemistry and pharmacology. J Ethnopharmacol. 2014;153(1):1-18.

Gaffen SL. Recent advances in the IL-17 cytokine family. Curr Opin Immunol. 2011;23(5):613-9.

Agache I, Ciobanu C, Agache C, Anghel M. Increased serum IL-17 is an independent risk factor for severe asthma. Respiratory Medicine. 2010;104(8):1131-7.

Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133(5):775-87.

Burzyn D, Kuswanto W, Kolodin D, Jennifer LS, Massimiliano C, Young J, et al. A special population of regulatory T cells potentiates muscle repair. Cell. 2013;155(6):1282-95.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respiratory Med. 2020;8(4):420-22.

Patel VK, Shirbhate E, Patel P, Veerasamy R, Sharma PC, Rajak H. Corticosteroids for treatment of COVID-19: Effect, evidence, expectation and extent. Beni-Suef University J Basic Applied Sci. 2021;10:78.

Rizvi SAA, Einstein GP, Tulp OL, Sainvil F, Branly R. Introduction to Traditional Medicine and Their Role in Prevention and Treatment of Emerging and Re-Emerging Diseases. Biomolecules. 2022;12(10):1442.

Rathore S, Raj Y, Debnath P, Kumar M, Kumar R. Ethnopharmacology, phytochemistry, agrotechnology, and conservation of Inula racemosa Hook. f.: A critically endangered medicinal plant of the western Himalaya. J Ethnopharmacol. 2022;283:114613.

Wangchuk P, Jamtsho T. Inula racemosa Hook. f. (Pushkarmool): Its ethnobotanical uses, phytochemicals, and pharmacological activities. James Cook University. 2023.

Yang G, Yang L, Xu F. Isoalantolactone: A review on its pharmacological effects. Front Pharmacol. 2024;15:1372428.

Tan L, Li J, Wang Y, Tan R. Anti-neuroinflammatory effect of alantolactone through the suppression of the NF-κB and MAPK signaling pathways. Cells. 2019;8(7):739.

Dang X, He B, Ning Q, Liu Y, Guo J, Niu G, et al. Alantolactone suppresses inflammation, apoptosis and oxidative stress in cigarette smoke-induced human bronchial epithelial cells through activation of Nrf2/HO-1 and inhibition of the NF-κB pathways. Respiratory Res. 2020;21:95.

Jiang C, Masood M, Rasul A, Wei W, Wang Y, Ali M, et al. Alantolactone inhibits NF-κB and STAT3 activation and induces reactive oxygen species-mediated apoptosis in prostate cancer DU145 cells. Molecules. 2017;22(10):1707.

Liu X, Bian L, Duan X, Zhuang X, Sui Y, Yang L. Alantolactone: A sesquiterpene lactone with diverse pharmacological effects. Chem Biol Drug Des. 2021;98(6):1131-5.

Dang X, He B, Ning Q, Liu Y, Guo J, Niu G, Chen M. Alantolactone suppresses inflammation, apoptosis and oxidative stress in cigarette smoke-induced human bronchial epithelial cells through activation of Nrf2/HO-1 and inhibition of the NF-κB pathways. Respir Res. 2020;21(1):95.

He G, Zhang X, Chen Y, Chen J, Li L, Xie Y. Isoalantolactone inhibits LPS-induced inflammation via NF-κB inactivation in peritoneal macrophages and improves survival in sepsis. Biomed Pharmacother. 2017;90:598-607.

Sharma RK, Arora R. Herbal Drugs: A Twenty-First Century Perspective. Jaypee Digital. 2006: 688.

Kirtikar KR, Basu BD. Indian Medicinal Plants. 2nd ed. Dehradun: International Book Distributors. 1999.

Government of India, Ministry of AYUSH. The Ayurvedic Pharmacopoeia of India. Part I, Vol. II. New Delhi: Ministry of AYUSH; Inula racemosa monograph.

Wangchuk P. Inula racemosa Hook.f. (Pushkarmool): Ethnobotany, phytochemistry and pharmacological activities. Plants. 2024.

Rathore S, Debnath P, Kumar R. Inula racemosa: A critically endangered medicinal plant with therapeutic potential. J Ethnopharmacol. 2022;283:114613.

OECD. Guidance Document on Good in Vitro Method Practices (GIVIMP). Paris: OECD Publishing. 2020.

Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal Transduction and Targeted Therapy. 2017;2:17023.

Chen L, Deng H, Cui H, Jing F, Zhicai Z, Junliang D, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018;9:7204-18.

Thompson BT, Chambers RC, Liu KD. Acute respiratory distress syndrome. N Eng J Med. 2017;377:562-72.

Yang G, Yang L, Xu F. Isoalantolactone: A review on its pharmacological effects. Front Pharmacol. 2024;15:1453205.

Tan L, Li J, Wang Y, Tan R. Anti-neuroinflammatory effect of alantolactone through suppression of NF-κB and MAPK signaling pathways. Cells. 2019;8:739.

Dang X, He B, Ning Q, Ya L, Jianxin G, Gang N, et al. Alantolactone suppresses inflammation, apoptosis and oxidative stress through activation of Nrf2/HO-1 and inhibition of NF-κB pathways. Respiratory Res. 2020;21(1):95.